Gregory M. Glenn

ORCID: 0000-0002-2030-8665

Also affiliated with Novavax (United States), Western Regional Research Center

MedicineMaterials ScienceImmunology and MicrobiologyNursing

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines”.

SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines

Cell Host & Microbe(2021)10.1016/j.chom.2021.03.002

N/A

10.9DataRank · unranked

395 citations

Haili Tang, Charlene McDanal, Kshitij Wagh, Will Fischer, James Theiler +12 more

NVX-CoV2373 vaccination induces functional SARS-CoV-2–specific CD4+ and CD8+ T cell responses

Journal of Clinical Investigation(2022)10.1172/jci160898

N/A

0.617DataRank · unranked

60 citations

Christina Kim, José Mateus, Joyce S. Plested, Mingzhu Zhu, Shane Cloney-Clark +6 more

SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.27.428516

N/A

0DataRank · unranked

79 citations

Haili Tang, Charlene McDanal, Kshitij Wagh, Will Fischer, James Theiler +13 more

Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico

medRxiv(2021)10.1101/2021.10.05.21264567

N/A

0DataRank · unranked

37 citations

Karen L. Kotloff, Cynthia L. Gay, Germán Áñez, Jeffrey Adelglass, Alejandro Quintín Barrat Hernández +29 more

Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 in nonhuman primates following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.02.05.429759

N/A

0DataRank · unranked

34 citations

Nita Patel, Mimi Guebre‐Xabier, Alex Zhu, Caroline Atyeo, Krista M. Pullen +26 more

Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination

Research Square(2021)10.21203/rs.3.rs-200342/v1

N/A

0DataRank · unranked

13 citations

Matthew J. Gorman, Nita Patel, Mimi Guebre‐Xabier, Alex Zhu, Caroline Atyeo +26 more

Immunogenicity of NVX-CoV2373 in PREVENT-19: A Phase 3, Randomized, Placebo-Controlled Trial in Adults in the United States and Mexico

medRxiv(2023)10.1101/2023.05.08.23289670

N/A

0DataRank · unranked

1 citations

Karen L. Kotloff, Cynthia L. Gay, J C Nelson, Haoua Dunbar, Shane Cloney-Clark +7 more

Safety and immunogenicity of four sequential doses of NVX-CoV2373 in adults and adolescents: a phase 3, randomized, placebo-controlled trial (PREVENT-19)

medRxiv(2024)10.1101/2024.11.07.24316930

N/A

0DataRank · unranked

0 citations

Alice McGarry, Wayne Woo, Karen L. Kotloff, Cynthia L. Gay, Mingzhu Zhu +14 more

Safety and immunogenicity of four sequential doses of NVX-CoV2373 in adults and adolescents: A phase 3, randomized, placebo-controlled trial (PREVENT-19)

Vaccine(2025)10.1016/j.vaccine.2025.127362

N/A

0DataRank · unranked

3 citations

Alice McGarry, Wayne Woo, Karen L. Kotloff, Cynthia L. Gay, Mingzhu Zhu +15 more

Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination

Cell Reports Medicine(2021)10.1016/j.xcrm.2021.100405

N/A

0DataRank · unranked

147 citations

Nita Patel, Mimi Guebre‐Xabier, Alex Zhu, Caroline Atyeo, Krista M. Pullen +26 more